scholarly article | Q13442814 |
P2093 | author name string | Malmborg AS | |
Karlsson M | |||
Wretlind B | |||
Nilsson-Ehle I | |||
Hammers S | |||
P2860 | cites work | Treatment of the Early Manifestations of Lyme Disease | Q22241125 |
New Chemotherapeutic Approaches in the Treatment of Lyme Borreliosis | Q22242308 | ||
Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice | Q33754842 | ||
Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis | Q34330551 | ||
Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis | Q34613449 | ||
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents | Q35281053 | ||
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents | Q35536241 | ||
Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis | Q35566456 | ||
Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis | Q35646489 | ||
Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. | Q36989113 | ||
Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction | Q37122905 | ||
Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis | Q37227753 | ||
Antibiotic treatment in Lyme borreliosis | Q37499658 | ||
Treatment of Lyme borreliosis with emphasis on neurological disease | Q39540057 | ||
Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans | Q43970732 | ||
Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study | Q44300217 | ||
Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years | Q44700572 | ||
Neurosyphilis and penicillin levels in cerebrospinal fluid | Q45205280 | ||
The use of doxycycline in nervous system Borrelia burgdorferi infection. | Q45273492 | ||
Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study | Q47581031 | ||
Doxycycline carrageenate--an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate. | Q51597518 | ||
Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease. | Q54340410 | ||
Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans | Q58402734 | ||
The Spirochetal Etiology of Lyme Disease | Q58402764 | ||
Clinical manifestations and diagnosis of neuroborreliosis | Q67966890 | ||
European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility | Q69007212 | ||
Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis | Q69080706 | ||
Evaluation of a micromethod for determination of antibiotic concentrations in plasma | Q69242341 | ||
Doxycycline blood levels in normal subjects after intravenous and oral administration | Q69379655 | ||
In vitro and in vivo susceptibility of Borrelia burgdorferi | Q69421586 | ||
Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G | Q69429410 | ||
Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin | Q70178390 | ||
Single versus multiple dose doxycycline prophylaxis in elective colorectal surgery | Q70371884 | ||
Serum and Cerebrospinal Fluid Concentrations of a New Tetracycline, Doxycycline | Q72426389 | ||
Penicillin concentrations in cerebrospinal fluid and serum after intramuscular, intravenous, and oral administration to syphilitic patients | Q72703858 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebrospinal fluid | Q54196 |
Lyme disease | Q201989 | ||
benzylpenicillin | Q258450 | ||
doxycycline | Q422442 | ||
P304 | page(s) | 1104-1107 | |
P577 | publication date | 1996-05-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis | |
P478 | volume | 40 |
Q90028021 | An unexpectedly high occurrence of aciclovir-induced neuropsychiatric symptoms in patients treated for herpesvirus CNS infection: a prospective observational study |
Q33977417 | Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents |
Q36679488 | Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know |
Q37072897 | Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie |
Q53688834 | Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics. |
Q42163224 | Blocking human fear memory with the matrix metalloproteinase inhibitor doxycycline |
Q38100704 | Clinical pharmacokinetics of antibacterials in cerebrospinal fluid. |
Q91803575 | Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis |
Q79770430 | Diagnosis and treatment of the neuromuscular manifestations of lyme disease |
Q34372745 | Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study |
Q40303844 | Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines |
Q36020841 | Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline |
Q60937233 | Looking at the positives: proactive management of STIs in people with HIV |
Q73762957 | Lyme borreliosis |
Q35207029 | Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA. |
Q46529042 | Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial |
Q35990112 | Orientia, rickettsia, and leptospira pathogens as causes of CNS infections in Laos: a prospective study |
Q34142328 | Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections |
Q36083619 | Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing. |
Q47135235 | Practical considerations for choosing a mouse model of Alzheimer's disease |
Q33436124 | Severe human monocytic ehrlichiosis presenting with altered mental status and seizures |
Q37683108 | Spirochetal infections |
Q34761872 | Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease. |
Q46110072 | Tet system in the brain: transgenic rats and lentiviral vectors approach. |
Q38842593 | Tet-On Systems For Doxycycline-inducible Gene Expression. |
Q90729704 | Threat Memory Reminder Under Matrix Metalloproteinase 9 Inhibitor Doxycycline Globally Reduces Subsequent Memory Plasticity |
Search more.